K-numberK251480
Device namePV01 PVDF Effort Sensor
ApplicantNeurotronics, LLC
Product codeSFK
Device classClass II
Decision dateAug 29, 2025
DecisionSubstantially Equivalent
Regulation
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The PV01 PVDF Effort Sensor is a respiratory monitoring accessory used during sleep studies to measure chest and abdominal wall movement. It consists of a piezoelectric PVDF sensing element housed in plastic enclosures connected by a silicone-laminated film, paired with an elastic belt that wraps around the patient's chest or abdomen. The device outputs voltage signals proportional to breathing effort for analysis by sleep clinicians to diagnose sleep disorders, and is intended for use in hospitals, sleep labs, clinics, nursing homes, or home environments under medical professional direction.

Technological characteristics

The Subject Device uses piezoelectric PVDF sensing technology, whereas the Predicate Device (RIP01) uses respiratory inductance plethysmography (RIP) technology. However, both measure the same physiological parameter (respiratory effort), produce identical output signal ranges (0–1000 µV peak-to-peak, 0.1–15 Hz), offer the same connector options (1.5 mm DIN or keyhole), rely on the host system for patient isolation, and do not require power from the host. The Subject Device has a reusable sensor module with a single-use belt, whereas the Predicate Device has both reusable components.

Test standards cited

UL 60601-1:2003 Ed.1 + R:26 Apr 2006 (dielectric strength, ingress of liquids, patient leads sections).

Substantial equivalence argument

Although the Subject and Predicate Devices employ different sensing technologies (PVDF versus RIP), they share substantially equivalent intended use, target population (adults and children), environments of use, contraindications, and functional outputs. The Subject Device demonstrated equivalent performance to a reference device using the same PVDF technology in a comparative breathing simulation test, and all safety tests passed UL standards. The use of established low-risk materials identical to or derived from predicate and reference devices with long clinical histories, combined with minimal skin contact and comprehensive validation testing showing safe and effective performance, establishes substantial equivalence despite the technological difference.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →